|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn933591214 |
| 003 |
OCoLC |
| 005 |
20231120112045.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
160101t20162016enka ob 000 0 eng d |
| 040 |
|
|
|a YDXCP
|b eng
|e rda
|e pn
|c YDXCP
|d N$T
|d OCLCQ
|d OPELS
|d OCLCF
|d COO
|d USU
|d MMU
|d TMC
|d OCLCO
|d UIU
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d Z5A
|d CASUM
|d OCLCO
|d MERER
|d OCLCQ
|d OCLCO
|d OCLCA
|d U3W
|d BUF
|d OCLCO
|d OCLCQ
|d D6H
|d NLE
|d UKMGB
|d OCLCO
|d OCLCA
|d LQU
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCL
|
| 015 |
|
|
|a GBB6F4543
|2 bnb
|
| 015 |
|
|
|a GBB6H8738
|2 bnb
|
| 016 |
7 |
|
|a 017799484
|2 Uk
|
| 016 |
7 |
|
|a 017691624
|2 Uk
|
| 019 |
|
|
|a 981886556
|a 1105180402
|a 1105573713
|
| 020 |
|
|
|a 9780128020098
|q (electronic bk.)
|
| 020 |
|
|
|a 0128020091
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128019177
|q (paperback)
|
| 020 |
|
|
|z 0128019174
|q (paperback)
|
| 035 |
|
|
|a (OCoLC)933591214
|z (OCoLC)981886556
|z (OCoLC)1105180402
|z (OCoLC)1105573713
|
| 050 |
|
4 |
|a RC924.5.L85
|
| 060 |
|
4 |
|a 2016 E-016
|
| 060 |
|
4 |
|a WD 380
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.7/72
|2 23
|
| 082 |
0 |
4 |
|a 616.77
|2 22
|
| 245 |
0 |
0 |
|a Systemic lupus erythematosus :
|b basic, applied and clinical aspects /
|c edited by George C. Tsokos.
|
| 264 |
|
1 |
|a London :
|b Academic Press is an imprint of Elsevier,
|c [2016]
|
| 264 |
|
4 |
|c �2016
|
| 300 |
|
|
|a 1 online resource (xxv, 600 pages) :
|b illustrations (chiefly color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 336 |
|
|
|a still image
|b sti
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a History of systemic lupus erythematosus -- The patient -- Epidemiology -- Measuring disease activity -- Disease development and outcomes -- Socioeconomic aspects of systemic lupus erythematosus -- Biomarkers in systemic lupus erythematosus -- Overview of the pathogenesis of systemic lupus erythematosus -- Systemic lupus erythematosus and the environment -- Genes and genetics in human systemic lupus erythematosus -- Hormones -- The complement system in systemic lupus erythematosus -- T cells -- Integrating current thinking on peripheral B-celltolerance in lupus -- Neutrophils in systemic lupus erythematosus -- The role of dendritic cells in systemic lupus erythematosus -- Cytokines -- Toll-like receptors, systemic lupus erythematosus -- The interferon system in lupus erythematosus -- Humoral pathogenesis : Fc[gamma] receptors in autoimmunity and end-organ damage -- Apoptosis, autophagy, and necrosis -- Infections in early systemic lupus erythematosus pathogenesis -- Origin of autoantibodies -- Anti-DNA antibodies -- Antihistone and antispliceosome antibodies -- Immune complexes in systemic lupus erythematosus -- Microrna in systemic lupus erythematosus -- Oxidative stress in systemic lupus erythematosus : causes, consequences, and treatment -- Reactive nitrogen intermediates in the pathogenesis of systemic lupus erythematosus -- Epigenetics -- What do mouse models teach us about human systemic lupus erythematosus? -- Genes and genetics of murine systemic lupus erythematosus -- Mechanisms of renal damage in systemic lupus erythematosus -- Mechanisms of vascular damage in systemic lupus erythematosus -- The mechanism of skin damage -- Pathogenesis of tissue injury in the brain in patients with systemic lupus erythematosus -- Constitutional symptoms and fatigue in systemic lupus erythematosus -- The musculoskeletal system in systemic lupus erythematosus -- Cutaneous lupus erythematosus -- The clinical evaluation of kidney disease in systemic lupus erythematosus -- The pathology of lupus nephritis -- Cardiovascular disease in systemic lupus erythematosus -- The lung in systemic lupus erythematosus -- Gastrointestinal, hepatic, and pancreatic disorders in systemic lupus erythematosus -- Systemic lupus erythematosus and infections -- Malignancies in systemic lupus erythematosus -- The nervous system in systemic lupus erythematosus -- Overlap syndromes -- Systemic lupus erythematosus and the eye -- Pregnancy and fertility in systemic lupus erythematosus -- Neonatal lupus : clinical spectrum, biomarkers, pathogenesis, and approach to treatment -- Incomplete lupus -- Childhood-onset systemic lupus erythematosus -- Drug-induced lupus -- Vasculitis in lupus -- Pathogenesis of antiphospholipid syndrome -- Antibodies and diagnostic tests in antiphospholipid syndrome -- Clinical manifestations -- Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus -- Value of antimalarial drugs in the treatment of lupus -- Systemic glucocorticoids -- Cytotoxic-immunosuppressive drug treatment -- Treatment of antiphospholipid syndrome -- New treatments for systemic lupus erythematosus -- Management lessons from clinical trials of kidney disease in systemic lupus erythematosus -- Repositioning drugs for systemic lupus erythematosus.
|
| 588 |
0 |
|
|a Online resource; title from resource home page (ClinicalKey, viewed April 12, 2017).
|
| 650 |
|
0 |
|a Systemic lupus erythematosus.
|
| 650 |
|
0 |
|a Biochemical markers.
|
| 650 |
|
0 |
|a Comorbidity.
|
| 650 |
1 |
2 |
|a Lupus Erythematosus, Systemic
|x diagnosis
|0 (DNLM)D008180Q000175
|
| 650 |
|
2 |
|a Lupus Erythematosus, Systemic
|0 (DNLM)D008180
|
| 650 |
|
2 |
|a Multimorbidity
|0 (DNLM)D000076322
|
| 650 |
2 |
2 |
|a Lupus Erythematosus, Systemic
|x physiopathology
|0 (DNLM)D008180Q000503
|
| 650 |
2 |
2 |
|a Lupus Erythematosus, Systemic
|x therapy
|0 (DNLM)D008180Q000628
|
| 650 |
2 |
2 |
|a Biomarkers
|0 (DNLM)D015415
|
| 650 |
2 |
2 |
|a Comorbidity
|0 (DNLM)D015897
|
| 650 |
|
6 |
|a Lupus �eryth�emateux diss�emin�e.
|0 (CaQQLa)201-0250523
|
| 650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
| 650 |
|
6 |
|a Comorbidit�e.
|0 (CaQQLa)201-0319011
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Comorbidity.
|2 fast
|0 (OCoLC)fst00871254
|
| 650 |
|
7 |
|a Biochemical markers.
|2 fast
|0 (OCoLC)fst00831950
|
| 650 |
|
7 |
|a Systemic lupus erythematosus.
|2 fast
|0 (OCoLC)fst01141443
|
| 700 |
1 |
|
|a Tsokos, George C.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Systemic lupus erythematosus.
|d London : Elsevier/Academic Press, [2016]
|z 9780128019177
|w (OCoLC)926743093
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128019177
|z Texto completo
|
